Journal
BIOCHEMISTRY
Volume 60, Issue 32, Pages 2471-2482Publisher
AMER CHEMICAL SOC
DOI: 10.1021/acs.biochem.1c00437
Keywords
-
Categories
Funding
- NIH [R35GM122603, R01-GM117593, AI119187, AI144887]
- EPSRC [EP/L015382/1]
- Molecular Sciences Software Institute Fellowship
- Chiesi Hellas (SARG grant) [10354]
- National Center for Research Resources Grant [1S10RR027234-01]
- Relay Therapeutics
Ask authors/readers for more resources
Studies have shown that there are slight differences in the way (R)- and (S)-rimantadine bind to the M2 WT channel, but this does not affect the drug's efficacy or binding kinetics.
The influenza A M2 wild-type (WT) proton channel is the target of the anti-influenza drug rimantadine. Rimantadine has two enantiomers, though most investigations into drug binding and inhibition have used a racemic mixture. Solid-state NMR experiments using the full length-M2 WT have shown significant spectral differences that were interpreted to indicate tighter binding for (R)-vs (S)-rimantadine. However, it was unclear if this correlates with a functional difference in drug binding and inhibition. Using X-ray crystallography, we have determined that both (R)- and (S)-rimantadine bind to the M2 WT pore with slight differences in the hydration of each enantiomer. However, this does not result in a difference in potency or binding kinetics, as shown by similar values for k(on), k(off), and K-d in electrophysiological assays and for EC50 values in cellular assays. We concluded that the slight differences in hydration for the (R)- and (S)-rimantadine enantiomers are not relevant to drug binding or channel inhibition. To further explore the effect of the hydration of the M2 pore on binding affinity, the water structure was evaluated by grand canonical ensemble molecular dynamics simulations as a function of the chemical potential of the water. Initially, the two layers of ordered water molecules between the bound drug and the channel's gating His37 residues mask the drug's chirality. As the chemical potential becomes more unfavorable, the drug translocates down to the lower water layer, and the interaction becomes more sensitive to chirality. These studies suggest the feasibility of displacing the upper water layer and specifically recognizing the lower water layers in novel drugs.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available